HP reports Q2 revenue up 3.3% YoY to $13.22B, vs. $13.14B est., Personal Systems revenue up 7% to $9B, and Q3 forecast below est.; HPQ drops 15%+
Context & Ripple Effects
HP’s results extend a recovery from the prior-year contraction, when its Personal Systems business was reported down 29% in Q2 2023. More recently, growth had been returning but forecasts were already a pressure point: Q1 Personal Systems revenue rose 5% while HP’s Q2 earnings outlook trailed expectations.
The current quarter accelerates Personal Systems growth to 7% and puts total revenue modestly above estimates, but the below-consensus Q3 outlook breaks the link between a better reported quarter and investor confidence.
First-order effects
- HP’s 7% Personal Systems revenue increase to $9 billion is the principal source of the quarter’s growth, while the weaker Q3 forecast immediately resets expectations for the next reporting period.
- HPQ’s drop of more than 15% shows investors are discounting the outlook rather than rewarding the revenue beat.
Second-order effects
- The split between revenue performance and guidance will put greater scrutiny on whether HP can convert Personal Systems growth into results that meet expectations; that issue was also visible in HP’s earlier below-expectation profit outlook.
- For HP’s commercial-PC customers and channel partners, the forecast becomes a near-term signal to watch in planning around HP’s demand and earnings trajectory, rather than treating the reported revenue beat as a definitive recovery marker.
Third-order effects
- If revenue growth repeatedly fails to support expected forward earnings, PC-hardware companies may be valued increasingly on the durability and profitability of growth, not on top-line recovery alone.
- The pattern points to a sector in which forecast credibility is becoming as consequential as quarterly sales growth, though HP’s subsequent execution will determine whether this is a persistent constraint or a single-quarter reset.
The trend: HP’s quarter is one data point in the PC industry’s shift from judging recovery by sales stabilization to judging it by the quality and predictability of forward earnings.